Can-Fite BioPharma (NYSE:CANF – Free Report) had its price objective reduced by D. Boral Capital from $11.00 to $4.00 in a research report sent to investors on Wednesday,Benzinga reports. They currently have a buy rating on the stock. CANF has been the subject of several other reports. HC Wainwright reaffirmed a “buy” rating and issued […]

SouthState Bank (NYSE:SSB – Get Free Report) had its price objective reduced by Barclays from $125.00 to $122.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective points to a potential upside of 25.48% from the stock’s current price. Other analysts […]